CME webinar: Hepatitis C, B, and HIV: Screening and Management
Mar. 2024Education/Webinars
Please join us for a live, continuing medical education (CME)-accredited webinar on Wednesday, May 1, from noon to 1 p.m. The webinar will provide an overview of hepatitis C, B, and HIV screening and management. During this presentation, our expert will:
Presenter:
Nicholas DeGregorio, MD, MMM, FACP,
Associate Vice President, Medicaid Medical Services, UPMC Health Plan
Register now.
This webinar will be recorded.
This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
This activity has been designated as and meets the Pennsylvania licensure requirement for Patient Safety-Risk Management Credit. It is the responsibility of the learner to maintain the educational presentation or conference agenda as evidence, if needed for audit purposes.
Provider is responsible for verifying CME eligibility.
- Review the prevalence, trends, and screening recommendations for hepatitis B, C, and HIV.
- Discuss recommended screening tests and the interpretation of the results.
- Review the management of hepatitis C and the role of primary care in its treatment.
- Discuss considerations with hepatitis C, B, and HIV coinfections.
Presenter:
Nicholas DeGregorio, MD, MMM, FACP,
Associate Vice President, Medicaid Medical Services, UPMC Health Plan
Register now.
This webinar will be recorded.
This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
This activity has been designated as and meets the Pennsylvania licensure requirement for Patient Safety-Risk Management Credit. It is the responsibility of the learner to maintain the educational presentation or conference agenda as evidence, if needed for audit purposes.
Provider is responsible for verifying CME eligibility.
Recent Announcements
Voluntary nationwide recall: Ocaliva (Intercept – September)
Intercept Pharmaceuticals, Inc. is voluntarily withdrawing Ocaliva® (obeticholic acid) from the market. Ocaliva is used to treat a rare liver disease called primary biliary cholangitis (PBC).Oct. 2025Pharmacy Updates
HelpScript service helps patients enroll in manufacturer copay assistance programs
End-to-end provider support helps ensure a smooth submission processOct. 2025Important Notices
Important announcement – Telehealth submissions
As of October 1, 2025, UPMC Health Plan continues to accept the submission of telehealth claims. Providers may conduct telehealth visits for UPMC Health Plan members in all UPMC Insurance products. UPMC Insurance products include UPMC Advantage group and individual products, UPMC for Life Medicare Advantage plans, UPMC for Kids CHIP plans, UPMC Community HealthChoices, and UPMC for You Medical Assistance plans.Sep. 2025Important Notices